Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001762932 | SCV001988928 | uncertain significance | not provided | 2020-11-25 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25163546) |
Ambry Genetics | RCV002386516 | SCV002702592 | uncertain significance | Cardiovascular phenotype | 2020-01-02 | criteria provided, single submitter | clinical testing | The p.M344K variant (also known as c.1031T>A), located in coding exon 11 of the CASQ2 gene, results from a T to A substitution at nucleotide position 1031. The methionine at codon 344 is replaced by lysine, an amino acid with similar properties. This alteration was reported in a dilated cardiomyopathy (DCM) cohort (Haas J et al. Eur. Heart J., 2015 May;36:1123-35a). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV003346667 | SCV004050773 | uncertain significance | Catecholaminergic polymorphic ventricular tachycardia 2 | 2023-04-11 | criteria provided, single submitter | clinical testing |